Science
Mechanism of Action
This ingredient operates by significantly inhibiting inflammatory cytokines (e.g., MCP-1, IP-10, VCAM-1) and tissue remodeling molecules (e.g., EGFR, MMP-1, PAI-1) to reduce skin inflammation. Its antimicrobial action involves disrupting bacterial cell membranes and inhibiting ATPase activity. As an antioxidant, it neutralizes free radicals via DPPH and ABTS inhibition. For anti-aging, it reduces melanin production by inhibiting tyrosinase and protects skin integrity by inhibiting collagenase and elastase enzymes.
Research
Clinical Evidence
Medium confidence0.01%
Key findings
- 01 At a very low concentration of 0.0012%, it significantly reduced inflammatory cytokines and tissue remodeling molecules in a human dermal fibroblast system, demonstrating potent anti-inflammatory effects.
- 02 In vitro, concentrations between 0.0125% and 0.1% (125-1000 µg/mL) showed notable antioxidant activity, increasing DPPH inhibition from 8.22% to 28.74%.
- 03 At concentrations below 0.01% (<100 µg/mL), it was non-cytotoxic to human fibroblast cells and effectively inhibited tyrosinase (61.68% - 93.12%), collagenase (2.83% - 30.28%), and elastase (4.37% - 33.92%) activities.
- 04 Demonstrated significant antibacterial activity against Staphylococcus aureus with a minimum inhibitory concentration of 0.16% (1.6 mg/mL).
Transparency
Dusting Analysis
This ingredient contains cinnamaldehyde, a prime allergen, which must not exceed 0.1% in the final cosmetic product. Given the oil's typical cinnamaldehyde content of 50-90%, this strict limit necessitates that the Cinnamomum Zeylanicum Bark Oil itself does not exceed approximately 0.2% in formulation (derived from 0.1% / 0.50 cinnamaldehyde content). Formulators must exercise extreme precision to avoid exceeding these limits, as even slight overuse can lead to sensitization and irritation, rendering it susceptible to 'dusting' where it's included for minor benefits without due consideration for its safety profile.
The Formula
Formulation
Stability
The oil is chemically stable under recommended handling and storage, but exposure to extreme heat should be avoided. No specific optimal pH range for stability was identified, however, it shows incompatibility with strong acids and alkalis.
Conflicts
- strong acids
- alkalis
- oxidizing agents
- extreme heat
Safety
Safety Profile
European regulations indicate that this ingredient can cause skin irritation and allergic skin reactions, with its primary sensitizer, cinnamaldehyde, restricted to a maximum of 0.1% in finished cosmetic products. This inherently limits the oil's concentration to approximately 0.2%. While the FDA lists 'Cinnamon Bark, Oil (Cinnamomum spp.)' as Generally Recognized As Safe (GRAS) for food flavoring, this does not extend to its topical use in cosmetic formulations, where its high irritancy and sensitization potential are significant concerns.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite its promising anti-inflammatory, antioxidant, anti-aging, and antibacterial properties, the high irritancy and sensitization risk, primarily due to its cinnamaldehyde content, warrant extreme caution and precise formulation, making its widespread use questionable for a precision skincare brand.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources